文献速递衰弱、肌少症与跌倒

SARC-F及其改良版用于肌少症筛查的信度与同时效度:系统综述与Meta分析

Reliability and Concurrent Validity of the SARC-F and Its Modified Versions: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Am Med Dir Assoc · 2021-06-16

该系统综述与Meta分析纳入29篇文献共21855名成人,评估SARC-F及其改良版筛查肌少症的信度与同时效度。SARC-F信度良好,但灵敏度低至中等(28.9%-55.3%)、特异度中等至高(68.9%-88.9%);SARC-CalF灵敏度45.9%-57.2%、特异度87.7%-91.3%。结论认为SARC-F不宜单独用于肌少症筛查,建议直接应用诊断标准。

要点

  • SARC-F信度良好,但灵敏度低至中等,不适合单独用于肌少症筛查。
  • SARC-CalF特异度高(87.7%-91.3%),灵敏度仍为低至中等(45.9%-57.2%)。
  • 推荐不经过筛查,直接应用肌少症诊断标准进行诊断。

核心结论

  • SARC-F信度良好,但灵敏度低至中等、特异度中等至高,用于肌少症筛查并非最优。
  • 建议不经过筛查,直接应用肌少症诊断标准。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、Cochrane和CINAHL(2013年1月1日至2020年4月6日)。
  • 纳入29篇文献,共21855名成人(平均年龄63.3±14.6岁,女性61.3%),涵盖社区、老年住院、老年门诊、养老院和长期护理人群。

主要发现

  • SARC-F的评定者间信度好(2/4篇)至优(2/4篇),重测信度中等(1/6篇)至好(5/6篇),内部一致性低(4/8篇)至高(4/8篇)。
  • SARC-F灵敏度28.9%-55.3%,特异度68.9%-88.9%(依据EWGSOP、EWGSOP2、AWGS、FNIH、IWGS等定义)。
  • SARC-CalF灵敏度45.9%-57.2%,特异度87.7%-91.3%(依据EWGSOP、AWGS、FNIH、IWGS定义)。

关键数值与推荐

  • SARC-F灵敏度28.9%-55.3%,特异度68.9%-88.9%。
  • SARC-CalF灵敏度45.9%-57.2%,特异度87.7%-91.3%。

临床怎么用

  • 老年医学科不应仅依赖SARC-F筛查肌少症,因其灵敏度低至中等可能漏诊。
  • 可直接按照国际肌少症诊断标准进行评估,无需先经SARC-F筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sarcopenia, being prevalent in up to 40% of older adults, is associated with adverse health outcomes. The international sarcopenia guidelines recommend screening for sarcopenia using the SARC-F. A previous meta-analysis (2017) reported poor validity of the SARC-F among community-dwelling older adults. Since then, modified SARC-F versions were developed and new sarcopenia definitions were published, including the SARC-F for case-finding. This systematic review and meta-analysis aimed to assess the reliability of the SARC-F and its concurrent validity to identify sarcopenia. DESIGN: Systematic review and meta-analyses. SETTING AND PARTICIPANTS: Adults (all ages) from any study population. METHODS: A systematic search was conducted in MEDLINE, EMBASE, Cochrane, and CINAHL (January 1, 2013, to April 6, 2020). Articles were included if they reported on the reliability and/or concurrent validity of the (modified) SARC-F. No restrictions were applied for sex, age, study population, or sarcopenia definition. Reliability measures included inter-rater reliability, test-retest reliability, and internal consistency. Meta-analyses were performed for concurrent validity. RESULTS: The 29 included articles included 21,855 individuals (mean age of 63.3±14.6 years, 61.3% females) among community-dwelling (n = 16), geriatric inpatient (n = 5), geriatric outpatient (n = 2), nursing home (n = 2), and long-term care (n = 1) populations. The SARC-F had good (2/4 articles) to excellent (2/4 articles) inter-rater reliability, moderate (1/6 articles) to good (5/6 articles) test-retest reliability, and low (4/8 articles) to high (4/8 articles) internal consistency. The SARC-F had low to moderate sensitivity (28.9%-55.3%) and moderate to high specificity (68.9%-88.9%) according to the European Working Group on Sarcopenia in Older People (EWGSOP; n = 13), revised EWGSOP definition (EWGSOP2; n = 6), Asian Working Group for Sarcopenia (AWGS; n = 13), Foundation for the National Institutes of Health (FNIH; n = 8), International Working Group on Sarcopenia (IWGS; n = 9), and Society on Sarcopenia, Cachexia and Wasting Disorders (n = 2). The SARC-CalF had low to moderate sensitivity (45.9%-57.2%) and high specificity (87.7%-91.3%) according to the EWGSOP (n = 5), AWGS (n = 4), FNIH (n = 3), and IWGS (n = 3). CONCLUSIONS AND IMPLICATIONS: Despite the good reliability of the SARC-F, its low to moderate sensitivity and moderate to high specificity make it nonoptimal to use for sarcopenia screening. It is recommended to apply the diagnostic criteria for sarcopenia without screening.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Voelker SN, Michalopoulos N, Maier AB, et al. Reliability and Concurrent Validity of the SARC-F and Its Modified Versions: A Systematic Review and Meta-Analysis. J Am Med Dir Assoc. 2021. PMID: 34144049. doi:10.1016/j.jamda.2021.05.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。